Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031655
Filing Date
2022-11-14
Accepted
2022-11-14 08:30:36
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1106416
2 ex31-1.htm EX-31.1 15468
3 ex31-2.htm EX-31.2 15473
4 ex-32.htm EX-32 12746
  Complete submission text file 0001493152-22-031655.txt   5150149

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20220930.xsd EX-101.SCH 32577
6 XBRL CALCULATION FILE abeo-20220930_cal.xml EX-101.CAL 65000
7 XBRL DEFINITION FILE abeo-20220930_def.xml EX-101.DEF 169354
8 XBRL LABEL FILE abeo-20220930_lab.xml EX-101.LAB 343863
9 XBRL PRESENTATION FILE abeo-20220930_pre.xml EX-101.PRE 275475
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 734327
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 221380610
SIC: 2834 Pharmaceutical Preparations